# Medtronic Launches New Diabetes Technology Integrated with Abbott Sensor
December 4, 2025 (Global) – Medtronic has unveiled a new diabetes management system integrated with Abbott’s continuous glucose monitoring (CGM) sensor, marking a major advancement in connected and automated diabetes care. This collaboration aims to provide patients with a more seamless, accurate, and user-friendly approach to glucose monitoring and insulin delivery.
“By combining Medtronic’s insulin delivery technology with Abbott’s trusted CGM sensor, we are empowering patients to manage diabetes more effectively and with greater confidence,” said [Medtronic Executive Name].
The system allows real-time glucose data from Abbott’s sensor to guide insulin dosing decisions, helping patients maintain better glycemic control while reducing the daily burden of diabetes management. Designed for ease of use, the technology supports automated therapy adjustments and enhanced patient outcomes.
Key Highlights of the Launch
- New Medtronic system integrated with Abbott CGM sensor for real-time glucose monitoring
- Supports smarter insulin dosing and improved glycemic control
- Focus on reducing patient burden and improving usability
- Enhances connected care and digital health for diabetes management
Industry analysts note that this integration exemplifies the growing trend toward interoperable diabetes technologies, providing patients and clinicians with greater flexibility, data-driven insights, and personalized care options.
“Collaborations like this are key to advancing automated and patient-centered diabetes management,” said [Industry Analyst Name]. “It highlights how medical technology partnerships can improve both clinical outcomes and patient experience.”
